Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

American Healthcare REIT (AHR) Cost of Revenue (2017 - 2025)

American Healthcare REIT (AHR) has disclosed Cost of Revenue for 9 consecutive years, with $480.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue rose 11.55% year-over-year to $480.3 million, compared with a TTM value of $1.8 billion through Dec 2025, up 8.44%, and an annual FY2025 reading of $1.8 billion, up 8.44% over the prior year.
  • Cost of Revenue was $480.3 million for Q4 2025 at American Healthcare REIT, up from $454.5 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $480.3 million in Q4 2025 and bottomed at $14.5 million in Q3 2021.
  • Average Cost of Revenue over 5 years is $351.0 million, with a median of $373.6 million recorded in 2023.
  • The sharpest move saw Cost of Revenue plummeted 70.72% in 2021, then skyrocketed 2221.09% in 2022.
  • Year by year, Cost of Revenue stood at $277.8 million in 2021, then increased by 29.88% to $360.8 million in 2022, then grew by 6.7% to $385.0 million in 2023, then grew by 11.83% to $430.6 million in 2024, then rose by 11.55% to $480.3 million in 2025.
  • Business Quant data shows Cost of Revenue for AHR at $480.3 million in Q4 2025, $454.5 million in Q3 2025, and $426.3 million in Q2 2025.